Evolving Clinical–Translational Investigations of Cerebroprotection in Ischemic Stroke
Open Access
- 24 October 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (21) , 6715
Abstract
Ischemic stroke is a highly morbid disease, with over 50% of large vessel stroke (middle cerebral artery or internal carotid artery terminus occlusion) patients suffering disability despite maximal acute reperfusion therapy with thrombolysis and thrombectomy. The discovery of the ischemic penumbra in the 1980s laid the foundation for a salvageable territory in ischemic stroke. Since then, the concept of neuroprotection has been a focus of post-stroke care to (1) minimize the conversion from penumbra to core irreversible infarct, (2) limit secondary damage from ischemia-reperfusion injury, inflammation, and excitotoxicity and (3) to encourage tissue repair. However, despite multiple studies, the preclinical–clinical research enterprise has not yet created an agent that mitigates post-stroke outcomes beyond thrombolysis and mechanical clot retrieval. These translational gaps have not deterred the scientific community as agents are under continuous investigation. The NIH has recently promoted the concept of cerebroprotection to consider the whole brain post-stroke rather than just the neurons. This review will briefly outline the translational science of past, current, and emerging breakthroughs in cerebroprotection and use of these foundational ideas to develop a novel paradigm for optimizing stroke outcomes.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (K08NS121597-01A1)
- Stony Brook University Research Foundation (K08NS121597-01A1)
This publication has 186 references indexed in Scilit:
- The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injuryActa Neuropathologica, 2012
- Preclinical stroke research – advantages and disadvantages of the most common rodent models of focal ischaemiaBritish Journal of Pharmacology, 2011
- Mechanisms of Leukocyte Transendothelial MigrationAnnual Review of Pathology: Mechanisms of Disease, 2011
- Neuroprotection in Subarachnoid HemorrhageStroke, 2010
- The Science of Stroke: Mechanisms in Search of TreatmentsNeuron, 2010
- Stroke research at a road block: the streets from adversity should be paved with meta‐analysis and good laboratory practiceBritish Journal of Pharmacology, 2009
- Effects of NXY‐059 in experimental stroke: an individual animal meta‐analysisBritish Journal of Pharmacology, 2009
- The Low-Density Lipoprotein Receptor-Related Protein 1 Mediates Tissue-Type Plasminogen Activator-Induced Microglial Activation in the Ischemic BrainThe American Journal of Pathology, 2009
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Behavioral tests for preclinical intervention assessmentNeuroRX, 2006